Browsing by author "Hueston, Linda"
Sort by:
Title A-Z
-
The antibody response to SARS-CoV-2 infection
Hueston, Linda; Kok, Jen; Guibone, Ayla; McDonald, Damien; Hone, George; Goodwin, James; Carter, Ian; Basile, Kerri; Sandaradura, Indy; Maddocks, Susan; Sintchenko, Vitali; Gilroy, Nicole; Chen, Sharon; Dwyer, Dominic E; O’Sullivan, Matthew V NPublished 2020Abstract Background Testing for SARS-CoV-2-specific antibodies has become an important tool, complementing nucleic acid tests (NATs) for diagnosis and for determining the prevalence of COVID-19 in population serosurveys. ...Article -
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
Rockett, Rebecca J.; Draper, Jenny; Gall, Mailie; Sim, Eby M.; Arnott, Alicia; Agius, Jessica E.; Johnson-Mackinnon, Jessica; Fong, Winkie; Martinez, Elena; Drew, Alexander P.; Lee, Clement; Ngo, Christine; Ramsperger, Marc; Ginn, Andrew N.; Wang, Qinning; Fennell, Michael; Ko, Danny; Hueston, Linda; Kairaitis, Lukas; Holmes, Edward C.; O’Sullivan, Matthew N.; Chen, Sharon C.-A.; Kok, Jen; Dwyer, Dominic E.; Sintchenko, VitaliPublished 2022Co-infections with different variants of SARS-CoV-2 are a key precursor to recombination events that are likely to drive SARS-CoV-2 evolution. Rapid identification of such co-infections is required to determine their ...Article -
An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population
Wehrhahn, Michael C; Brown, Suzanne J; Newcombe, James P; Chong, Smathi; Evans, Jenny; Figtree, Melanie; Hainke, Laurence; Hueston, Linda; Khan, Sadid; Marland, Elizabeth; O'Sullivan, Matthew V N; Powell, Helen; Roy, Jhumur; Waring, Lynette; Yu, Megan; Robson, JenniferPublished 2021A total of 1080 individual patient samples (158 positive serology samples from confirmed, predominantly mildly symptomatic COVID-19 patients and 922 serology negative including 496 collected pre-COVID) from four states in ...Article -
High rate of persistent symptoms up to 4 months after community and hospital-managed SARS-CoV-2 infection
Darley, David R; Dore, Gregory J; Cysique, Lucette; Wilhelm, Kay A; Andresen, David; Tonga, Katrina; Stone, Emily; Byrne, Anthony; Plit, Marshall; Masters, Jeffrey; Tang, Helen; Brew, Bruce; Cunningham, Philip; Kelleher, Anthony; Matthews, Gail; Mistry, Sandeep G; Walker, Wallace; Earnshaw, James; Cervin, Anders; Gidding, Heather F; Machalek, Dorothy A; Hendry, Alexandra J; Quinn, Helen E; Vette, Kaitlyn; Beard, Frank H; Shilling, Hannah; Hirani, Rena; Gosbell, Ian B; Irving, David O; Hueston, Linda; Downes, Marnie; Carlin, John B; O'Sullivan, Matthew NV; Dwyer, Dominic E; Kaldor, John M; Macartney, Kristine; d'Emden, Michael C; Ungerer, Jacobus PJ; de Jersey, Susan J; Johnston, Kate; Tyson, Chloe; Danny, Indra; Meyer, Lois; Heriot, George S; Jamrozik, Euzebiusz; Way, Teagan L; Tarrant, Seth M; Balogh, Zsolt L; Stanaway, Fiona; Irwig, Les; Teixeira-Pinto, Armando; Bell, Katy J.L.; Horvath, Andrea R; Loy, Clement; Burrell, Aiden JC; Pellegrini, Breanna; Salimi, Farhad; Begum, Husna; Broadley, Tessa; Campbell, Lewis T; Cheng, Allen C; Cheung, Winston; Cooper, D James; Earnest, Arul; Erickson, Simon J; French, Craig J; Litton, Edward; Murthy, Srinivas; McAllister, Richard; Nichol, Alistair; Palermo, Annamaria; Plummer, Mark; Ramanan, Mahesh; Reddi, Benjamin; Reynolds, Claire; Trapani, Tony; Webb, Steven AR; Udy, Andrew; Hao Tran, Tu; Sasikumar, Suraj Narayanan; Hennessy, Annamarie; O’Loughlin, Aiden; Morgan, Lucy; Blakely, Tony; Thompson, Jason; Carvalho, Natalie; Bablani, Laxman; Wilson, Nick; Stevenson, Mark; Scott, Nick; Palmer, Anna; Delport, Dominic; Abeysuriya, Romesh; Stuart, Robyn; Kerr, Cliff C; Mistry, Dina; Klein, Daniel; Sacks-Davis, Rachel; Heath, Katie; Hainsworth, SamuelPublished 2020Recovery after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains uncertain. A considerable proportion of patients experience persistent symptoms after SARS-CoV-2 infection which impacts ...Open AccessArticle -
SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers
Hasan, Tasnim; Lim, H Ling; Hueston, Linda; Dwyer, Dominic E; O'Sullivan, MatthewPublished 2021Article -
Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020
Gidding, Heather F; Machalek, Dorothy A; Hendry, Alexandra J; Quinn, Helen E; Vette, Kaitlyn; Beard, Frank H; Shilling, Hannah S; Hirani, Rena; Gosbell, Iain B; Irving, David O; Hueston, Linda; Downes, Marnie; Carlin, John B; O'Sullivan, Matthew VN; Dwyer, Dominic E; Kaldor, John M; Macartney, KristinePublished 2021OBJECTIVES: To estimate SARS-CoV-2-specific antibody seroprevalence after the first epidemic wave of coronavirus disease 2019 (COVID-19) in Sydney. SETTING, PARTICIPANTS: People of any age who had provided blood for testing ...Article -
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey
Vette, Kaitlyn M; Machalek, Dorothy A; Gidding, Heather F; Nicholson, Suellen; O'Sullivan, Matthew V N; Carlin, John B; Downes, Marnie; Armstrong, Lucy; Beard, Frank H; Dwyer, Dominic E; Gibb, Robert; Gosbell, Iain B; Hendry, Alexandra J; Higgins, Geoff; Hirani, Rena; Hueston, Linda; Irving, David O; Quinn, Helen E; Shilling, Hannah; Smith, David; Kaldor, John M; Macartney, KristinePublished 2022Background: As of mid-2021, Australia's only nationwide coronavirus disease 2019 (COVID-19) epidemic occurred in the first 6 months of the pandemic. Subsequently, there has been limited transmission in most states and ...Article
Sort by:
Title A-Z